These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8086568)

  • 1. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
    Zahid MA; Klotz SA; Goldstein E; Bartholomew W
    Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P; Sultan F; Wallace RJ; Fraser V
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
    Wallace RJ; Tanner D; Brennan PJ; Brown BA
    Ann Intern Med; 1993 Sep; 119(6):482-6. PubMed ID: 8357113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
    Driscoll MS; Tyring SK
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):495-6. PubMed ID: 9091495
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin.
    Franck N; Cabié A; Villette B; Amor B; Lessana-Leibowitch M; Escande JP
    J Am Acad Dermatol; 1993 Jun; 28(6):1019-21. PubMed ID: 8496448
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
    Chung WK; Kim MS; Kim CH; Lee MW; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2009 Nov; 89(6):663-4. PubMed ID: 19997711
    [No Abstract]   [Full Text] [Related]  

  • 9. Sporotrichoid Mycobacterium chelonae.
    Orrin E; Worsnop F; Natkunarajah J
    Australas J Dermatol; 2016 Aug; 57(3):244-5. PubMed ID: 27469486
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells.
    Valencia IC; Weiss E; Sukenik E; Kerdel FA
    Int J Dermatol; 1999 Oct; 38(10):770-3. PubMed ID: 10561050
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycobacterium chelonae infection involving the auricle.
    Lin YH; Liu TC
    QJM; 2012 Oct; 105(10):1021-2. PubMed ID: 21908384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of subcutaneous nodules after mesotherapy].
    Ramos A; Roustan G; Lucena JL; Daza RM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):775-7. PubMed ID: 21722998
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis.
    Bañuls J; Ramón R; Pascual E; Navas J; Betlloch I; Botella R
    Br J Dermatol; 2000 Dec; 143(6):1345. PubMed ID: 11122063
    [No Abstract]   [Full Text] [Related]  

  • 14. Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.
    Kullavanijaya P; Rattana-Apiromyakij N; Sukonthapirom-Napattalung P; Sirimachand S; Duangdeeden I
    J Dermatol; 2003 Jun; 30(6):485-91. PubMed ID: 12810998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium chelonae keratitis in a patient with Sjögren's syndrome.
    Van Der Beek MT; Bernards AT; Lapid-Gortzak R
    Eur J Ophthalmol; 2008; 18(2):294-6. PubMed ID: 18320526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of cutaneous Mycobacterium chelonae abscessus infection in a renal transplant patient.
    Endzweig CH; Strauss E; Murphy F; Rao BK
    J Cutan Med Surg; 2001; 5(1):28-32. PubMed ID: 11281431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent therapy resistant mastoiditis by Mycobacterium cheilonae abscessus, a nontuberculous mycobacterium.
    van Aarem A; Muytjens HL; Smits MM; Cremers CW
    Int J Pediatr Otorhinolaryngol; 1998 Feb; 43(1):61-72. PubMed ID: 9596371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter related line sepsis resulting from Mycobacterium chelonae infection in an immunocompromised host.
    Antony SJ
    Infect Disord Drug Targets; 2015; 15(2):135-7. PubMed ID: 26205798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.